Cargando…
SAT005 Effect Of OSU-ERβ-12, A Carborane-based ERβ-selective Agonist, On Hepatic Fibrosis And NASH
Disclosure: P. Kumar: None. T.H. Helms: None. H. Radomska: None. W. Tyler: None. S.K. Kulp: None. C. Bennett: None. C.C. Coss: None. Background: Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease worldwide. NAFLD includes a range of conditions from simple steatosis t...
Autores principales: | Kumar, Pankaj, Helms, Timothy H, Radomska, Hanna, Tyler, Wilson, Kiyota Kulp, Samuel, Bennett, Chad, Charles Coss, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554242/ http://dx.doi.org/10.1210/jendso/bvad114.1743 |
Ejemplares similares
-
SAT021 Development Of Niclosamide Analogs For Treatment Of Androgen Receptor Positive Hepatocellular Carcinoma
por: Jordan Montgomery, Emma, et al.
Publicado: (2023) -
SAT-LB004 Therapeutic Potential of LPCN 1144 in NAFLD and NASH
por: Baker, Jonathan, et al.
Publicado: (2019) -
SAT-005 Gene Expression and Behavioral Alterations in Mice with Conditional Knockout of GR, MR, or Both GR and MR in the Hippocampus
por: Oakley, Robert, et al.
Publicado: (2019) -
SAT-LB005 Association of Serum Estrogens and Estrogen Metabolites with Use of Non-Steroidal Anti-Inflammatory Drugs in Postmenopausal Women
por: Fuhrman, Barbara, et al.
Publicado: (2019) -
Studying the Genomic Role of Cathepsin-D in ER(+) Breast Cancer
por: Dianati, Elham, et al.
Publicado: (2021)